MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

Pelthos Therapeutics has secured the rights to market non-fluorinated quinolone antimicrobial, Xepi (ozenoxacin) Cream, 1% in ...

Alongside their role in mental health, psychedelics are also emerging in neurological and inflammation-driven diseases.

SanegeneBio has formed a research and licensing partnership with Eli Lilly and Company to develop RNAi candidates for ...

Harbour BioMed and Evinova China have formed a collaboration to implement AI and digital technologies to improve biologics ...

One of the most compelling acquisition sagas in the pharma industry in recent times has come to an end, with Pfizer prevailing over Novo Nordisk in a fierce bidding war to acquire ...

The biopharma industry of Europe can use AI to leverage its vast stores of health data to address key challenges.

Approval of J&J's Darzalex marks a milestone for high-risk sMM patients, but GlobalData analyst Biswajit Podder believes ...

ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the ...

Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...

Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the MHRA for all four formulations of ...